Bupivacaine Hydrochloride Injection — FDA Drug Shortage

Current — Somerset Therapeutics, LLC

The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on Feb 20, 2018. Reported reason: Other

Shortage details

Status
Current
Company
Somerset Therapeutics, LLC
Package NDC
70069-752-01
Dosage Form
Injection
Presentation
Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01)
Initial Posting
Feb 20, 2018

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.